Segmentectomy for NSCLC: a better alternative?

医学 肺癌 磨玻璃样改变 腺癌 楔形切除术 外科 癌症 内科学 切除术
作者
Xu Song,Chunxia Su
出处
期刊:The Lancet Respiratory Medicine [Elsevier BV]
卷期号:11 (6): 497-498 被引量:1
标识
DOI:10.1016/s2213-2600(23)00076-0
摘要

Two large, multicentre, phase 3 trials, JCOG0802/WJOG4607L 1 Saji H Okada M Tsuboi M et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022; 399: 1607-1617 Summary Full Text Full Text PDF PubMed Scopus (247) Google Scholar and CALGB140503, 2 Altorki N Wang X Kozono D et al. Lobar or sublobar resection for peripheral stage IA non-small-cell lung cancer. N Engl J Med. 2023; 388: 489-498 Crossref PubMed Scopus (24) Google Scholar provided evidence that segmentectomy, as a surgical procedure, could be used without compromising oncological therapeutic outcome compared with lobectomy in early stage non-small-cell lung cancer (NSCLC) with a tumour 2 cm or less in size and a consolidation-to-tumour ratio (CTR) more than 0·5. Previous studies have also shown that sublobar resection for patients with cT1aN0 NSCLC with a predominant ground-glass opacity (GGO) is feasible in terms of pulmonary function preservation, tolerable complications, and a favourable prognosis survival (table). 3 Nakao M Yoshida J Goto K et al. Long-term outcomes of 50 cases of limited-resection trial for pulmonary ground-glass opacity nodules. J Thorac Oncol. 2012; 7: 1563-1566 Summary Full Text Full Text PDF PubMed Scopus (81) Google Scholar , 4 Tsutani Y Miyata Y Nakayama H et al. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy. Chest. 2014; 145: 66-71 Summary Full Text Full Text PDF PubMed Scopus (237) Google Scholar , 5 Cho JH Choi YS Kim J Kim HK Zo JI Shim YM Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules. Ann Thorac Surg. 2015; 99: 218-222 Summary Full Text Full Text PDF PubMed Scopus (87) Google Scholar , 6 Sagawa M Oizumi H Suzuki H et al. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity. Eur J Cardiothorac Surg. 2018; 53: 849-856 Crossref PubMed Scopus (35) Google Scholar , 7 Suzuki K Watanabe S-I Wakabayashi M et al. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer. J Thorac Cardiovasc Surg. 2022; 163: 289-301.e2 Summary Full Text Full Text PDF PubMed Scopus (90) Google Scholar , 8 Qi Y-F Qiu Z-B Zhang C et al. Sublobectomy for stage IA1–2 invasive lung adenocarcinoma with consolidation tumor ratio≤ 0·25. Thorac Cancer. 2022; 13: 3174-3182 Crossref PubMed Scopus (1) Google Scholar However, the efficacy and safety of segmentectomy for tumours more than 2 cm in size still needs to be identified. TableSummary of studies on sublobar resection of stage IA non-small-cell lung cancer with a CTR of 0·5 or less Study design Study phase Sample size Inclusion criteria Surgical type Postoperative pulmonary function Postoperative complications Outcomes Nakao et al (2012) 3 Nakao M Yoshida J Goto K et al. Long-term outcomes of 50 cases of limited-resection trial for pulmonary ground-glass opacity nodules. J Thorac Oncol. 2012; 7: 1563-1566 Summary Full Text Full Text PDF PubMed Scopus (81) Google Scholar Prospective study NA 40 ≤2 cm tumour size, CTR ≤0·50 Sublobar resection (n=26) vs lobectomy (n=14) NA NA 5-year relapse-free survival, 100% in both groups Tsutani et al (2014) 4 Tsutani Y Miyata Y Nakayama H et al. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy. Chest. 2014; 145: 66-71 Summary Full Text Full Text PDF PubMed Scopus (237) Google Scholar Retrospective study NA 239 ≤3 cm tumour size, CTR ≤0·50 Sublobar resection (n=149) vs lobectomy (n=90) NA NA 3-year relapse-free survival: sublobar resection, 97·7% vs lobectomy, 96·4%; 3-year overall survival: sublobar resection, 98·5% vs lobectomy, 97·6% Cho et al (2015) 5 Cho JH Choi YS Kim J Kim HK Zo JI Shim YM Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules. Ann Thorac Surg. 2015; 99: 218-222 Summary Full Text Full Text PDF PubMed Scopus (87) Google Scholar Retrospective study NA 71 ≤3 cm tumour size, CTR ≤0·25 Wedge resection NA NA 5-year relapse-free survival, 100%; 5-year overall survival, 100% Sagawa et al (2018) 6 Sagawa M Oizumi H Suzuki H et al. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity. Eur J Cardiothorac Surg. 2018; 53: 849-856 Crossref PubMed Scopus (35) Google Scholar Prospective study NA 72 ≤2 cm tumour size, CTR ≤0·25 Sublobar resection Postoperative average change in ratio of FEV1: by 3 months, 0·86, and by 1 year 0·96; vital capacity: by 3 months, 0·86, and by 1 year, 0·96 NA 5-year disease-specific survival, 100%; 5-year overall survival, 98·1% Suzuki et al (2022) 7 Suzuki K Watanabe S-I Wakabayashi M et al. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer. J Thorac Cardiovasc Surg. 2022; 163: 289-301.e2 Summary Full Text Full Text PDF PubMed Scopus (90) Google Scholar Prospective study 3 325 ≤2 cm tumour size, CTR ≤0·25 Sublobar resection Change from baseline median FEV1: −0·045 (IQR −0·37 to 0·49); forced vital capacity: −0·026 (−0·47 to 0·40) Grade 2 rate, 37·2%; grade 3 rate, 5·1% 5-year relapse-free survival, 99·7%; 5-year overall survival, 99·4% Qi et al (2022) 8 Qi Y-F Qiu Z-B Zhang C et al. Sublobectomy for stage IA1–2 invasive lung adenocarcinoma with consolidation tumor ratio≤ 0·25. Thorac Cancer. 2022; 13: 3174-3182 Crossref PubMed Scopus (1) Google Scholar Retrospective study NA 100 ≤2 cm tumour size, CTR ≤0·25 Sublobar resection (n=49) vs lobectomy (n=51) NA Sublobar resection, 2·0% vs lobectomy, 5·9% (p=0·62) 5-year lung cancer-specific overall survival, 100%; 5-year lung cancer-specific relapse-free survival, 100% in both groups CTR=consolidation-to-tumour ratio. NA=not available. Open table in a new tab CTR=consolidation-to-tumour ratio. NA=not available. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trialSegmentectomy should be considered as part of standard treatment for patients with predominantly GGO NSCLC with a tumour size of 3 cm or less in diameter, including GGO even if it exceeds 2 cm. Full-Text PDF
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava的应助被CC采纳,获得10
刚刚
大面包完成签到,获得积分10
刚刚
xxy完成签到,获得积分10
刚刚
上官若男的应助被大白采纳,获得10
1秒前
Owen的应助被可研小菜鸟采纳,获得10
1秒前
2秒前
chi2完成签到,获得积分10
2秒前
2秒前
fangzi完成签到,获得积分10
3秒前
3秒前
3秒前
yeo完成签到,获得积分10
4秒前
落寞的寒云完成签到,获得积分10
4秒前
TEXAS完成签到,获得积分10
4秒前
4秒前
bkagyin的应助被浅陌采纳,获得10
4秒前
4秒前
田様的应助被一叶知秋采纳,获得10
4秒前
陈天降低完成签到,获得积分10
5秒前
5秒前
大水桶发布了新的文献求助10
5秒前
咸鱼打滚完成签到,获得积分10
5秒前
xyc完成签到,获得积分10
7秒前
慕青的应助被鳗鱼水云采纳,获得10
7秒前
7秒前
LCFXR发布了新的文献求助10
8秒前
LL完成签到,获得积分10
8秒前
8秒前
micor发布了新的文献求助10
8秒前
8秒前
8秒前
8秒前
XialianWeng完成签到,获得积分10
9秒前
Hong发布了新的文献求助10
9秒前
zhawenchang发布了新的文献求助10
9秒前
xxy发布了新的文献求助10
10秒前
周舟发布了新的文献求助10
10秒前
laoying关注了科研通微信公众号
10秒前
第五彧轩发布了新的文献求助10
11秒前
苹果绝义完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8154161
求助须知:如何正确求助?哪些是违规求助? 9550701
关于积分的说明 21700590
捐赠科研通 7743260
什么是DOI,文献DOI怎么找? 3425651
关于科研通互助平台的介绍 2550861
邀请新用户注册赠送积分活动 2469363